Imprecise risk estimation of chemotherapy-related cardiotoxicity in HER2-positive breast cancer using the recently reported societal risk tools Osama SolimanAoife LoweryOn behalf of the Precision Cardio-Oncology Enterprise (P-CORE) Investigators Letter to the Editor 29 September 2021 Pages: 355 - 356
Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer Hannah Van BelleSara A. HurvitzHans Wildiers Review 17 September 2021 Pages: 357 - 372
Methionine restriction exposes a targetable redox vulnerability of triple-negative breast cancer cells by inducing thioredoxin reductase Dmitry MalinYoonkyu LeeVincent L. Cryns Preclinical study 22 September 2021 Pages: 373 - 387
Reduced menin expression leads to decreased ERα expression and is correlated with the occurrence of human luminal B-like and ER-negative breast cancer subtypes Romain TeinturierRazan Abou ZikiMuriel Le Romancer Preclinical study Open access 24 September 2021 Pages: 389 - 401
Expression of neurotensin receptor-1 (NTS1) in primary breast tumors, cellular distribution, and association with clinical and biological factors Clément MorgatVéronique BrousteElif Hindié Preclinical study 01 October 2021 Pages: 403 - 413
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study M. E. CazzanigaI. ValliniThe VICTOR Study Group Clinical trial Open access 21 September 2021 Pages: 415 - 424
A phase II study of sequential treatment with anthracycline and taxane followed by eribulin in patients with HER2-negative, locally advanced breast cancer (JBCRG-17) Ippei FukadaYoshinori ItoNorikazu Masuda Clinical trial Open access 23 September 2021 Pages: 425 - 434
Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin Nazli BahramiShakila JabeenJürgen Geisler Clinical trial Open access 23 September 2021 Pages: 435 - 449
Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients Linda ThorénMikael ErikssonSara Margolin Clinical trial Open access 27 September 2021 Pages: 451 - 462
Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1 Leonie NeirichMaryam Yahiaoui-DoktorSabine Grill Clinical trial Open access 27 September 2021 Pages: 463 - 475
Differential effects of CD20+ B cells and PD-L1+ immune cells on pathologic complete response and outcome: comparison between inflammatory breast cancer and locally advanced breast cancer patients Hugo Arias-PulidoAshley Marie Cimino-MathewsSteven Fiering Epidemiology 20 September 2021 Pages: 477 - 489
Population-based analysis of non-operative management and treatment patterns in older women with estrogen receptor-positive breast cancer David TejeraMariam RanaStephanie M. Wong Epidemiology 20 September 2021 Pages: 491 - 501
Trend and survival benefit of contralateral prophylactic mastectomy among men with stage I–III unilateral breast cancer in the USA, 1998–2016 Yinlong YangLiangwei PanZhiming Shao Epidemiology 23 September 2021 Pages: 503 - 515
Determinants of use of oral complementary-alternative medicine among women with early breast cancer: a focus on cancer-related fatigue Pietro LapidariNardjes DjehalAntonio Di Meglio Epidemiology 24 September 2021 Pages: 517 - 529
Clinical trial representativeness and treatment intensity in a real-world sample of women with early stage breast cancer Gabrielle B. RocqueNicole E. CastonRisha Gidwani Epidemiology 29 September 2021 Pages: 531 - 540
Sleep medication use and risk of fractures in breast cancer survivors Reina HaqueRowan T. ChlebowskiLieHong Chen Epidemiology Open access 29 September 2021 Pages: 541 - 548
Racial/ethnic disparities in risk of breast cancer mortality by molecular subtype and stage at diagnosis Nicole C. LoronaKathleen E. MaloneChristopher I. Li Epidemiology 15 October 2021 Pages: 549 - 558